Phosphagenics Limited announced Mr. Harry Rosen, founder and former CEO, will from date step down as President and Executive Director of the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0035 AUD | +16.67% | 0.00% | 0.00% |
16/05 | Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial | MT |
25/03 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
1st Jan change | Capi. | |
---|---|---|
0.00% | 84.44L | |
+48.67% | 5.87TCr | |
-2.76% | 4.13TCr | |
+36.42% | 3.92TCr | |
-11.22% | 2.74TCr | |
+9.25% | 2.65TCr | |
-23.10% | 1.9TCr | |
+1.88% | 1.25TCr | |
+26.43% | 1.21TCr | |
+21.74% | 1.19TCr |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Harry Rosen Steps Down as President and Executive Director of Phosphagenics Limited